Biota MC = $130m
Biota cash position @ merger will be approx $100m
BARDA grant of $231m free carry cost of commercialising LANI for ROW
HRV is Phase III ready
Stockpile replenishment of Relenza very soon (value?).
Conservative revenue of LANI and HRV assuming FDA approval = > $200m?
Revenue if/when there is a pandemic (?)
Actual value of LANI, HRV and rest of pipeline ascribed by the market = $30m
LT Investment = No brainer
- Forums
- ASX - By Stock
- BTA
- timeline for patience is almost at an end
timeline for patience is almost at an end, page-11
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online